Patents by Inventor Stuart J. Madden

Stuart J. Madden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11813231
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: November 14, 2023
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • Patent number: 11628150
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: April 18, 2023
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • Publication number: 20210338608
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: July 2, 2021
    Publication date: November 4, 2021
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
  • Publication number: 20210330618
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: July 2, 2021
    Publication date: October 28, 2021
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
  • Publication number: 20210330619
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: July 2, 2021
    Publication date: October 28, 2021
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
  • Patent number: 11020361
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: June 1, 2021
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • Publication number: 20210093590
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: November 20, 2020
    Publication date: April 1, 2021
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
  • Publication number: 20190070134
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: November 6, 2018
    Publication date: March 7, 2019
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
  • Publication number: 20170071885
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: April 15, 2016
    Publication date: March 16, 2017
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • Patent number: 8334281
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: December 18, 2012
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • Publication number: 20100163032
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: December 22, 2009
    Publication date: July 1, 2010
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden